Your browser doesn't support javascript.
loading
Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma.
Menéndez, Victoria; Solórzano, José L; García-Cosío, Mónica; Alonso-Alonso, Ruth; Rodríguez, Marta; Cereceda, Laura; Fernández, Sara; Díaz, Eva; Montalbán, Carlos; Estévez, Mónica; Piris, Miguel A; García, Juan F.
Afiliação
  • Menéndez V; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.
  • Solórzano JL; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.
  • García-Cosío M; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain.
  • Alonso-Alonso R; Pathology Department, Hospital Universitario Ramón y Cajal, 28034, Madrid, Spain.
  • Rodríguez M; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.
  • Cereceda L; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain.
  • Fernández S; Pathology Department, IIS Hospital Universitario Fundación Jiménez Díaz, 28040, Madrid, Spain.
  • Díaz E; Center for Biomedical Network Research on Cancer (CIBERONC), ISCIII, 28029, Madrid, Spain.
  • Montalbán C; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.
  • Estévez M; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain.
  • Piris MA; Translational Research, Fundación MD Anderson International España. Madrid, 28033, Madrid, Spain.
  • García JF; Pathology Department, MD Anderson Cancer Center Madrid, C/Arturo Soria, 270, 28033, Madrid, Spain.
Sci Rep ; 14(1): 710, 2024 01 06.
Article em En | MEDLINE | ID: mdl-38184757
ABSTRACT
Classic Hodgkin lymphoma (cHL) is characterized by a rich immune microenvironment as the main tumor component. It involves a broad range of cell populations, which are largely unexplored, even though they are known to be essential for growth and survival of Hodgkin and Reed-Sternberg cells. We profiled the gene expression of 25 FFPE cHL samples using NanoString technology and resolved their microenvironment compositions using cell-deconvolution tools, thereby generating patient-specific signatures. The results confirm individual immune fingerprints and recognize multiple clusters enriched in refractory patients, highlighting the relevance of (1) the composition of immune cells and their functional status, including myeloid cell populations (M1-like, M2-like, plasmacytoid dendritic cells, myeloid-derived suppressor cells, etc.), CD4-positive T cells (exhausted, regulatory, Th17, etc.), cytotoxic CD8 T and natural killer cells; (2) the balance between inflammatory signatures (such as IL6, TNF, IFN-γ/TGF-ß) and MHC-I/MHC-II molecules; and (3) several cells, pathways and genes related to the stroma and extracellular matrix remodeling. A validation model combining relevant immune and stromal signatures identifies patients with unfavorable outcomes, producing the same results in an independent cHL series. Our results reveal the heterogeneity of immune responses among patients, confirm previous findings, and identify new functional phenotypes of prognostic and predictive utility.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article